innat
immun
constitut
first
line
defens
pathogen
depend
pattern
recognit
host
pattern
recognit
receptor
recogn
microbi
molecul
uniqu
group
relat
microorgan
mcgreal
et
al
microbi
molecul
often
cell
wall
compon
microb
primarili
carbohydr
chain
lipopolysaccharid
peptidoglycan
lipoteicho
acid
medzhitov
lectin
key
member
pattern
recognit
receptor
could
function
phagocytosi
receptor
solubl
opsonin
agglutinin
mediat
pattern
recognit
takano
et
al
acid
amphioxu
intelectin
homolog
amphiitlnlik
clone
yan
et
al
situ
hybrid
studi
reveal
amphiitlnlik
transcript
express
skin
digest
tract
adult
amphioxu
express
upregul
upon
challeng
staphylococcu
aureu
agglutin
gramneg
gramposit
bacteria
agglutin
usual
achiev
interact
lectin
lipopolysaccharid
peptidoglycan
present
cell
wall
gramneg
gramposit
bacteria
lrhamnosebind
lectin
known
stl
oncorhynchu
mykiss
steelhead
trout
egg
recogn
lipoteicho
acid
lipopolysaccharid
major
compon
outer
membran
gramneg
gramposit
bacteria
respect
agglutin
bacillu
subtili
escherichia
coli
bind
inhibit
lrhamnos
tateno
et
al
zhu
et
al
found
argopecten
irradian
bay
scallop
ctype
lectin
known
ailec
use
express
sequenc
tag
rapid
amplif
cdna
end
techniqu
amino
acid
sequenc
lectin
high
homolog
ctype
lectin
anim
ctype
lectin
carbohydr
recognit
protein
classic
domain
contain
four
conserv
disulfid
bridg
two
extra
cystein
residu
amino
end
take
pivot
part
innat
immun
invertebr
express
lectin
transcript
mainli
detect
hepatopancrea
elev
h
challeng
vibrio
anguillarum
gramneg
bacterium
micrococcu
luteu
gramposit
bacterium
result
demonstr
lectin
constitut
induc
acutephas
protein
may
respons
immun
respons
toward
infect
caus
gramneg
gramposit
bacteria
lectin
holothuria
scabra
sea
cucumb
known
hsl
studi
role
immun
respons
result
show
broad
spectrum
bacteri
challeng
could
induc
express
hsl
glycoconjug
bacteri
cell
wall
involv
lectin
inhibit
growth
gramneg
e
coli
proteu
sp
serratia
sp
shigella
sp
gramposit
bacteria
streptococcu
sp
gowda
et
al
saito
et
al
isol
lipopolysaccharidebind
protein
design
hemocyt
horsesho
crab
limulu
lectinlik
natur
protein
show
agglutin
activ
gramneg
gramposit
bacteria
inhibit
growth
gramneg
bacteria
includ
e
coli
k
salmonella
minnesota
mutant
klebsiella
pneumonia
presum
recogn
carbohydr
compon
bacteri
cell
wall
tachycitin
purifi
tachypleu
tridentatu
horsesho
crab
hemocyt
show
amino
acid
sequenc
similar
chitinbind
lectin
singlechain
protein
molecular
mass
kda
inhibit
growth
gramneg
escherichia
klebsiella
salmonella
gramposit
bacteria
staphylococcu
valu
furthermor
tachycitin
found
agglutin
gramneg
gramposit
bacteria
activ
higher
toward
escherichia
strain
kawabata
et
al
schroder
et
al
purifi
tachylectinlik
protein
demospong
suberit
domuncula
protein
manifest
antibacteri
activ
e
coli
gramneg
bacteria
aureu
gramposit
bacteria
antibacteri
activ
result
inhibit
e
coli
lectin
concentr
respect
inhibit
percentag
aureu
rel
low
exhibit
inhibit
lectin
present
hemolymph
mani
bivalv
mollusk
known
import
involv
host
defens
mechan
takahashi
et
al
isol
lectin
known
plasma
ruditap
philippinarum
manila
clam
demonstr
bacteriostat
opson
properti
invad
bacteria
r
philippinarum
phagocyt
activ
hemocyt
lectinopson
vibrio
tubiashii
markedli
higher
toward
untreat
bacteria
besid
lectin
significantli
inhibit
growth
alteromona
haloplankti
tetramer
lectin
isol
ovari
teleost
cobia
rachycentron
canadum
lectin
exert
antibacteri
activ
e
coli
inhibit
ngai
ng
lectin
cvl
marin
spong
cliona
varian
display
cytotox
effect
gramposit
bacteria
b
subtili
aureu
result
show
lectin
concentr
exhibit
strong
antibacteri
activ
inhibit
b
subtili
increas
higher
lectin
concentr
reach
inhibit
potent
antibacteri
activ
also
observ
aureu
incub
lectin
reduc
bacteria
growth
howev
show
rel
low
inhibitori
effect
growth
gramneg
bacteria
pseudomona
aeruginosa
e
coli
moura
et
al
holanda
et
al
purifi
lectin
solieria
filiformi
red
alga
inhibit
growth
gramneg
bacteria
like
serratia
marcescen
salmonella
typhi
klebsiella
pneumonia
enterobact
aerogen
proteu
sp
p
aeruginosa
though
chang
growth
phase
log
exponenti
declin
observ
postul
bind
lectin
cell
surfac
receptor
gramneg
bacteria
enhanc
chang
nutrient
flow
thu
would
explain
bacteriostat
effect
involv
interact
lectin
effect
suggest
tunkijjanukij
olafsen
purifi
heterogen
sialic
acidbind
lectin
modiolu
modiolu
hors
mussel
hemolymph
recogn
bacteri
lipopolysaccharid
antibacteri
activ
test
differ
marin
bacteria
sensit
strain
includ
vibrio
anguillarum
vibrio
ordalii
vibrio
salmonicida
vibrio
viscosu
vibrio
wodani
aeromona
salmonicida
shewanella
putrefacien
purifi
lectin
express
stronger
activ
whole
hemolymph
lectin
react
sever
sialoglycoconjug
purifi
lipopolysaccharid
marin
vibrio
dead
rest
cell
number
bacteria
suggest
lectin
may
play
role
recognit
elimin
bacteria
enorm
number
lectin
hemagglutinin
isol
marin
organ
manifest
antifung
activ
agglutin
fungi
normal
test
part
lectin
character
agglutin
may
aid
clearanc
facilit
phagocytosi
lectin
usual
bind
agglutin
fungi
express
level
upregul
challeng
fungi
act
similar
manner
elimin
invad
pathogen
bacteria
antifung
lectin
discuss
topic
ctype
lectin
import
innat
immun
pathogen
recognit
cellcel
interact
ctype
lectin
dramat
upregul
amphioxu
brachiostoma
belcheri
challeng
saccharomyc
cerevisia
lectin
directli
kill
cerevisia
fashion
cell
wall
permeabil
antimicrobi
activ
dosedepend
strongli
suppress
microbi
growth
bind
microbi
cell
wall
polysaccharid
peptidoglycan
glucan
preced
microbicid
activ
result
disclos
lectin
interact
peptidoglycan
glucan
bound
yeast
kill
directli
yu
et
al
studi
anoth
ctype
lectin
known
purifi
argopecten
irradian
bay
scallop
express
level
upregul
consider
hepatopancrea
hemocyt
challeng
pichia
pastori
agglutin
p
pastori
lectin
inhibit
dmannos
collect
result
reveal
play
role
primit
acutephas
respons
yeast
act
key
pattern
recognit
receptor
innat
immun
system
bay
scallop
kong
et
al
anoth
ctype
lectin
antifung
effect
demonstr
lectin
known
ecctl
purifi
epinephelu
coioid
orangespot
grouper
wei
et
al
bound
aggreg
cerevisia
manner
express
upregul
challeng
cerevisia
serum
lectin
purifi
lampetra
japonica
lamprey
xue
et
al
classifi
intelectin
interlectin
new
type
extracellular
anim
lectin
glycanbind
receptor
bind
glycan
epitop
foreign
pathogen
host
system
express
induc
bacteri
stimul
vivo
lectin
show
agglutin
activ
candida
albican
find
suggest
play
import
role
innat
immun
yeast
intern
circulatori
system
lamprey
repertoir
natur
bioactiv
compound
isol
marin
organ
show
promis
medicin
potenti
cheung
et
al
marin
lectin
exhibit
strong
antimicrobi
activ
aforement
impli
potenti
candid
drug
design
develop
futur
although
mechan
marin
organ
defens
system
reveal
lectin
possibl
appli
antimicrobi
mechan
remain
examin
studi
molecular
mechan
action
li
et
al
ng
et
al
relationship
huang
et
al
zhou
sun
clinic
trial
help
research
investig
therapeut
effect
toxic
lectin
also
worthwhil
check
lectin
synerg
exist
antimicrobi
agent
result
investig
contribut
knowledg
correspond
antimicrobi
mechan
also
applic
clinic
viewpoint
perspect
drug
design
also
start
new
perspect
potenti
lectin
marin
speci
recent
year
marin
lectin
gave
import
clue
develop
antivir
drug
differ
viral
infect
particularli
human
immunodefici
viru
type
infect
bind
high
mannos
sugar
key
compoen
hiv
envelop
inhibit
conform
chang
keep
inact
nonfus
state
koharudin
gronenborn
due
breakthrough
number
antivir
therapeut
agent
base
marin
lectin
potenti
medicin
applic
new
effect
drug
antivir
treatment
liu
et
al
found
express
gene
paralichthi
olivaceu
flounder
reduc
poli
c
challeng
first
h
increas
significantli
beyond
h
galectin
class
lectin
bind
recombin
could
neutral
lymphocysti
diseas
viru
lcdv
inhibit
cytopathi
infect
cell
could
also
prevent
inflamm
lcdv
infect
express
mx
antivir
protein
head
kidney
gill
head
kidney
would
significantli
downregul
lcdv
inject
find
show
relat
antivir
activ
control
mx
gene
overexpress
allevi
lcdv
pathogen
luo
et
al
studi
antivir
gene
pmav
found
penaeu
monodon
shrimp
encod
amino
acid
protein
ctype
lectinlik
domain
pmav
gene
clone
protein
express
e
coli
purifi
recombin
protein
test
antivir
activ
vitro
grouper
iridoviru
inocul
grouper
embryo
cell
day
found
cell
kill
viru
inocul
cell
incub
pmav
protein
around
grouper
embryo
cell
remain
viabl
valu
protein
also
evinc
potent
antivir
activ
virusinduc
cytopathi
inhibit
fish
cell
line
neither
recombin
nativ
form
demonstr
agglutin
activ
toward
viru
suggest
antivir
mechan
pmav
protein
entail
inhibit
viru
target
host
cell
interact
lectin
recogn
specif
carbohydr
structur
proteoglycan
glycoprotein
glycolipid
result
regul
variou
cell
via
glycoconjug
physiolog
patholog
phenomena
apoptosi
induct
cancer
metastasi
differenti
carbohydr
recognit
bind
cell
cell
commun
cell
target
interact
recent
lectin
also
known
block
bind
viru
target
cell
would
prevent
viral
infect
dissemin
sato
hori
geyer
et
al
observ
envelop
heavili
glycosyl
possibl
nlink
glycosyl
site
approxim
molecular
weight
attribut
glycan
locat
glycosyl
site
glycan
highmannos
complex
glycoprotein
could
act
bind
site
variou
lectin
signific
involv
glycan
infect
make
possibl
clue
develop
agent
balzarini
et
al
microcysti
viridi
unicellular
freshwat
bloomform
cyanobacterium
show
transient
hemagglutin
activ
laboratori
cultur
stationari
phase
nonaer
condit
lectin
singl
polypeptid
amino
acid
residu
two
tandemli
repeat
homolog
domain
amino
acid
residu
viridi
lectin
bind
oligomannosid
submicromolar
affin
two
novel
carbohydr
recognit
domain
compos
four
noncontigu
region
residu
make
numer
intermolecular
contact
carbohydr
ligand
yamaguchi
et
al
lectin
inhibit
hiv
type
envelopemedi
cell
fusion
valu
nm
bewley
et
al
lectin
purifi
red
alga
kappaphycu
alvarezii
known
exhibit
antivir
activ
number
influenza
strain
includ
swine
influenza
viru
algal
lectin
suppress
viru
infect
specif
interact
target
high
mannos
type
nglycan
viral
surfac
antiinfluenza
viru
activ
test
differ
strain
includ
swine
influenza
viru
valu
nm
use
antiinfluenza
antibodi
immunofluoresc
microscopi
result
show
lectin
interf
viru
entri
host
cell
elisa
assay
result
demonstr
lectin
bound
directli
viral
envelop
protein
sato
et
al
lectin
purifi
green
alga
boodlea
coacta
known
bca
also
found
activ
influenza
virus
like
also
bound
high
mannosetyp
nglycan
besid
bca
high
specif
mannos
nonreduc
end
glycan
number
nonreduc
end
substitut
mannos
increas
bind
specif
also
increas
mechan
suppress
viru
infect
bca
could
also
interfer
entri
viru
host
cell
valu
nm
surfac
plasmon
reson
assay
show
high
associ
constant
valu
bca
hiv
envelop
addit
bca
demonstr
antiinfluenza
viru
activ
subtyp
subtyp
valu
nm
respect
sato
et
al
griffithsin
grft
lectinlik
protein
purifi
red
alga
griffithsia
sp
aqueou
extract
amino
acid
length
grft
regard
antihiv
protein
prevent
hiv
entri
host
cell
nativ
recombin
protein
show
strong
antivir
activ
differ
primari
isol
laboratori
strain
cell
macrophagetrop
valu
rang
nm
also
stop
infect
transmiss
celltocel
fusion
among
infect
uninfect
cell
concentr
rang
differ
test
interact
grft
done
found
grft
bound
glycoprotein
viru
envelop
glycosylationdepend
manner
block
gp
bind
receptorexpress
cell
mildli
inhibit
solubl
interact
solubl
bind
occur
monosaccharidedepend
manner
mannos
potent
inhibitor
inhibit
antibodi
antibodi
bind
find
demonstr
grft
bound
differ
viral
glycoprotein
could
potenti
lead
antihiv
agent
mori
et
al
grft
also
demonstr
synergist
activ
tenofovir
maraviroc
enfuvirtid
clade
c
combin
use
two
drug
enhanc
antivir
potenc
support
clinic
investig
preexposur
prophylaxi
ferir
et
al
besid
hiv
grft
also
activ
hepat
c
viru
meuleman
et
al
ebola
viru
barton
et
al
atyp
pneumonia
pathogen
coronavirus
keef
et
al
herp
simplex
viru
nixon
et
al
japanes
enceph
viru
ishag
et
al
lectin
cyanobacteria
cyanovirinn
chen
et
al
xiong
et
al
microvirin
husken
et
al
shahzadulhussan
et
al
scytovirin
alexandr
et
al
garrison
et
al
oscillatoria
agardhii
agglutinin
ferir
et
al
koharudin
et
al
consid
potenti
candid
combat
hiv
virusinfect
diseas
mechan
ie
interact
glycan
hiv
show
specif
high
mannos
carbohydr
surfac
heavili
glycosyl
envelop
hiv
endow
potent
antihiv
activ
howev
lectin
uniqu
properti
includ
number
carbohydr
recognit
site
specif
oligosaccharid
differ
may
account
differ
antivir
activ
husken
schol
usual
divid
two
intern
tandem
repeat
display
pronounc
homolog
domain
form
stabil
disulfid
bridg
amino
acid
sequenc
intern
align
repeat
present
tabl
overal
lectin
broad
antivir
activ
howev
grft
cyanovirinn
exhibit
superior
antihiv
activ
potent
husken
schol
woodrum
et
al
studi
extens
also
show
antivir
activ
envelop
virus
benefit
usag
antihiv
agent
infect
commonli
associ
sexual
transmit
virus
hepat
c
viru
herp
simplex
viru
hell
et
al
meuleman
et
al
nixon
et
al
yu
et
al
irrespect
potent
antivir
activ
antihiv
agent
candid
safeti
issu
extrem
importanct
also
contribut
lack
efficaci
use
cyanovirinn
safe
microbicid
rais
question
clearli
stimulatorymitogen
activ
induc
elev
amount
larg
number
cytokin
buffa
et
al
howev
test
preclinl
hiv
vagin
rectal
transmiss
model
prove
effect
safe
tsai
et
al
contrast
grft
broad
potent
antivir
activ
devoid
stimulatori
properti
kouokam
et
al
howev
less
chemic
physic
stabl
cyanovirinn
sum
two
lectin
disadvantag
nevertheless
still
stand
potenti
candid
develop
antihiv
agent
glycan
commonli
found
viru
surfac
aforement
glycanbind
lectin
promis
antivir
agent
could
use
prevent
control
viru
infect
although
mani
high
mannosebind
lectin
legum
famili
lectin
demonstr
exhibit
antihiv
activ
balzarini
et
al
algal
cyanobacteri
lectin
potent
compound
report
thu
far
compar
plant
lectin
inhibit
hiv
entri
host
cell
valu
picomolar
rnanomolar
ang
directli
bind
envelop
compar
plant
lectin
gener
show
higher
micromolar
rang
valu
lectin
also
demonstr
power
activ
hiv
influenza
virus
regardless
differ
strain
subtyp
effect
antivir
agent
alway
short
suppli
vaccin
product
sometim
time
high
demand
outbreak
antivir
mechan
lectin
strainindepend
may
practic
medicin
use
compar
antibodybas
antivir
agent
prone
antigen
shift
antigen
drift
substanti
amount
carbohydr
residu
viru
envelop
may
good
target
antibodi
treatment
howev
viru
strain
continu
chang
antigen
make
increas
number
glycosyl
site
order
evad
antibodi
action
result
may
advantag
use
lectin
prevent
drug
sinc
inactiv
differ
viru
strain
subtyp
collect
result
research
lectin
uncov
potenti
novel
antivir
agent
prevent
infect
besid
abil
block
hiv
entri
host
cell
lectin
sourc
inhibit
cytopath
effect
induc
product
antigen
thu
replic
viru
host
cell
wang
et
al
purifi
lectin
antivir
activ
known
cvl
polychaet
marin
worm
chaetopteru
variopedatu
size
activ
test
demonstr
earli
viru
replic
stage
lectin
inhibit
product
viral
antigen
cytopathi
valu
respect
also
stop
celltocel
fusion
among
hivinfect
normal
cell
action
start
earli
viru
replic
phase
may
due
block
gain
entri
target
cell
use
fluorescencebas
realtim
quantifi
pcr
cvl
block
viru
attach
concentr
respect
molchanova
et
al
purifi
nacetylglucosaminespecif
lectin
svl
anoth
polychaet
serpula
vermiculari
also
show
antihiv
activ
inhibit
cytopathi
viral
antigen
product
host
cell
valu
respect
luk
ianov
et
al
purifi
three
lectin
crenomytilu
grayanu
design
cgl
didemnum
ternatanum
design
dtl
dtla
cgl
manifest
high
specif
glycoprotein
mucin
type
dtl
nacetylglucosaminespecif
shorter
carbohydratebind
site
bound
nacetylglucosamin
residu
termin
dtla
nacetylglucosaminenacetylgalactosamin
heparinspecif
lectin
cgl
dtl
dtla
inhibit
syncytium
format
cell
induc
iiib
valu
respect
tumor
normal
cell
differ
surfac
structur
shown
select
agglutin
malign
tumor
cell
lectin
nearli
type
malign
cell
demonstr
alter
glycosyl
pattern
compar
normal
counterpart
powlesland
et
al
meticul
studi
cell
surfac
carbohydr
human
experiment
tumor
show
promin
alter
glycoprotein
presenc
larger
extens
branch
nlink
oligosaccharid
couldrey
green
branch
nglycan
tri
tetraantenna
oligosaccharid
increas
total
cell
surfac
termin
sialyl
malign
cell
typic
found
initi
stage
carcinogenesi
induc
oncogen
virus
oncogen
denni
et
al
lectin
recogn
carbohydr
moieti
nglycan
tumor
cell
would
function
therapeut
agent
via
apoptosi
induct
yao
et
al
studi
antitumor
activ
bighead
carp
aristichthi
nobili
lectin
known
ganl
purifi
gill
six
human
tumor
cell
line
test
antiprolif
activ
found
lectin
exhibit
strong
antitumor
activ
hela
cell
line
valu
rabelo
et
al
investig
mechan
apoptosi
induct
human
tumor
cell
marin
spong
lectin
isol
marin
spong
cinachyrella
apion
lectin
cal
studi
antiprolif
activ
three
human
tumor
cell
line
result
show
lectin
exhibit
highest
antiprolif
activ
toward
hela
cell
dosedepend
manner
also
found
lectin
probabl
induc
apoptosi
hela
cell
increas
express
proapoptot
protein
bax
enhanc
mitochondri
membran
permeabil
activ
caspas
cascad
induc
cell
cycl
arrest
phase
matsumoto
et
al
isol
lectin
known
halichondria
okadai
demospong
dival
cationindepend
exhibit
cytotox
activ
erythroleukemia
cell
jurkat
leukemia
cell
carbohydr
dosedepend
manner
nacetylgalactosamin
nacetyldglucosamin
residu
known
express
surfac
two
cell
line
cytotox
activ
inhibit
presenc
two
amino
sugar
result
suggest
lectinglycan
interact
play
pivot
role
cytotox
tumor
cell
line
bah
et
al
isol
rhamnosebind
lectin
oncorhynchu
tshawytscha
chinook
salmon
roe
demonstr
lectin
exhibit
cytotox
activ
toward
human
hepatoma
hep
breast
cancer
cell
queiroz
et
al
investig
antitumor
activ
lectin
known
cvl
isol
cliona
varian
spong
test
cancer
cell
line
found
jurkat
cell
cell
sensit
valu
respect
human
leukemia
cell
kill
due
induct
apoptosi
addit
lectin
experiment
result
confoc
fluoresc
microscopi
reveal
lectin
induc
cathepsin
b
releas
flow
cytometri
disclos
increas
apoptot
index
western
blot
demonstr
express
tumor
necrosi
factor
receptor
upregul
subunit
nuclear
factor
kappa
b
downregul
lectintr
cell
result
suggest
cathepsin
b
play
role
undefin
associ
apoptot
pathway
lectin
known
mytilec
purifi
fujii
et
al
mediterranean
mussel
mytilu
galloprovinciali
lectin
could
also
bind
globotrios
specif
lectin
exhibit
antiprolif
activ
human
burkitt
lymphoma
raji
cell
express
surfac
activ
inhibit
presenc
experiment
result
demonstr
lectin
relat
latestag
apoptosi
trigger
loss
membran
integr
cell
membran
invers
anoth
exampl
lectin
siluru
asotu
catfish
egg
lectin
design
sal
also
bound
express
surfac
burkitt
lymphoma
cell
found
size
lectintr
cell
smaller
untreat
cell
present
glycosphingolipidenrich
microdomain
involv
interact
brought
reduct
cell
size
activ
potassium
channel
result
provid
new
approach
understand
glucosphingholipidtarget
cancer
therapi
kawano
et
al
differ
harm
stimuli
provok
strong
inhibit
pain
sensat
evok
distant
region
bodi
tissu
injuri
inflamm
nociceptor
sensit
way
ineffect
weak
stimul
becom
pain
sensit
primari
affer
nociceptor
normal
inflammatori
pain
type
lead
hyperalgesia
andor
allodynia
state
human
known
nocicept
anim
model
kurihara
et
al
present
nonsteroid
antiinflammatori
drug
analgesiainduc
drug
opioid
suitabl
case
low
potenc
side
effect
ahmadiani
et
al
consequ
develop
altern
drug
becom
necessari
benefici
holothuria
grisea
agglutinin
hga
sea
cucumb
holothuria
grisea
use
test
antinocicept
antiinflammatori
activ
rat
dimer
mucinspecif
lectin
molecular
mass
kda
hga
inject
intraven
result
show
neutrophil
migrat
induc
carrageenan
periton
caviti
inhibit
selectin
known
induc
neutrophil
migrat
inflammatori
tissu
propos
hga
could
block
selectin
share
common
carbohydr
ligand
thu
selectin
action
stop
hga
also
exhibit
strong
antinocicept
effect
acet
acidinduc
writh
test
number
abdomin
constrict
reduc
significantli
hgatreat
group
intraperiton
inject
acet
acid
caus
local
irrit
induc
releas
differ
endogen
mediat
prostaglandin
bradykinin
substanc
p
tumor
necrosi
activ
chemosensit
nociceptor
caus
inflammatori
pain
collier
et
al
result
suggest
antinocicept
effect
may
caus
decreas
number
leukocyt
periton
caviti
inhibit
endogen
mediat
releas
induc
hga
administr
hga
show
antinocicept
effect
phase
inflammatori
phase
formalin
test
indic
effect
associ
inflammatori
pain
howev
hotplat
test
lectin
exhibit
nocicept
action
demonstr
hga
show
central
antinocicept
action
peripher
mechan
may
involv
instead
verifi
observ
formalin
test
antinocicept
effect
inflammatori
phase
treatment
hga
caus
increas
circul
nitric
oxid
level
inhibit
myeloperoxidas
activ
myeloperoxidas
peroxidas
usual
express
neutrophil
regard
direct
marker
neutrophil
decreas
myeloperoxidas
activ
agre
result
neutrophil
migrat
test
inhibit
migrat
may
associ
increas
circul
nitric
oxid
level
caus
hga
demonstr
express
adhes
molecul
downregul
nitric
oxid
vascular
endothelium
henc
decreas
number
neutrophil
migrat
inflammatori
region
lavich
et
al
result
show
hga
abil
modul
inflammatori
respons
vivo
model
moura
et
al
bitencourt
fda
et
al
test
mucinspecif
hypnea
cervicorni
agglutinin
hca
previous
purifi
red
marin
alga
hypnea
cervicorni
antinocicept
antiinflammatori
activ
mous
rat
model
hca
smoothen
paw
edema
rat
induc
carrageenan
induc
dextran
edema
induc
carrageenan
multimedi
tempor
incid
distinguish
massiv
neutrophil
migrat
srinivasan
et
al
contrari
dextran
proinflammatori
mediat
distinguish
increas
vascular
permeabl
without
involv
neutrophil
migrat
lo
et
al
result
demonstr
action
involv
inflammatori
process
relat
neutrophil
migrat
result
investig
shown
strong
link
inflamm
pain
develop
inhibit
neutrophil
migrat
allevi
hypernocicept
induc
differ
inflammatori
stimul
cunha
et
al
effect
inhibit
preincub
mucin
suggest
lectin
mucinspecif
particip
carbohydratebind
site
action
intraven
inject
mice
sign
toxic
observ
caus
renal
hepat
malfunct
affect
bodi
mass
macroscopi
liver
kidney
heart
investig
demonstr
antihypernocicept
effect
hca
relat
increas
nitric
oxid
product
nitric
oxid
allevi
hyperalgesia
activ
largininenocgmp
pathway
caus
direct
block
persist
acut
hypernocicept
open
k
atp
channel
stimul
protein
kinas
g
nune
et
al
sach
et
al
experiment
result
disclos
antinocicept
effect
hca
carrageenaninduc
hypernocicept
reduc
treatment
nitric
oxid
synthas
inhibitor
demonstr
nitric
oxid
may
associ
action
hca
figueiredo
et
al
anoth
lectin
purifi
marin
alga
amansia
multifida
mannosespecif
action
test
mice
interest
find
observ
formalin
hotplat
test
antinocicept
action
lectin
block
naloxon
indic
possibl
involv
opioid
system
neve
et
al
similar
result
obtain
test
antinocicept
antiinflammatori
activ
red
marin
alga
pterocladiella
capillacea
lectin
known
pcl
silva
et
al
green
marin
alga
caulerpa
cupressoid
lectin
known
ccl
vanderlei
et
al
conclus
aforement
marin
lectin
exhibit
strong
antinocicept
antiinflammatori
activ
howev
detail
mechan
yet
clarifi
investig
could
help
acquir
inform
develop
altern
therapi
pain
inflammatori
process
cutan
wound
origin
disrupt
skin
integr
could
major
troubl
public
health
postpon
heal
lack
proper
treatment
lead
complex
therapeut
problem
particularli
diabet
patient
heal
process
complex
arrang
wellord
phase
overlap
highli
special
cell
interact
extracellular
matrix
result
growth
tissu
repair
diegelmann
evan
lectin
purifi
bryothamnion
seaforthii
marin
red
alga
known
bsl
heal
potenti
studi
cutan
wound
made
mice
heal
test
mice
topic
treat
bsl
day
first
day
treatment
edema
hyperemia
observ
treat
group
indic
sign
proinflammatori
effect
bsl
decreas
wound
area
observ
result
histopatholog
examin
reveal
bsltreat
anim
experienc
epitheli
cover
restructur
keratin
product
cutan
immatur
annex
format
activ
collagen
format
reticular
dermi
region
fibroblast
activ
observ
sign
good
heal
portion
wound
closur
assess
term
wound
expos
area
progress
time
result
show
bsltreat
mice
experienc
faster
heal
increas
close
wound
area
result
demonstr
lectin
wound
heal
enhanc
effect
use
potenti
acut
wound
treatment
enhanc
heal
process
expedit
wound
closur
mechan
probabl
involv
trigger
immun
system
inflammatori
phase
follow
modul
growth
factor
cytokin
activ
collagen
synthesi
fibroblast
differenti
myofibroblast
use
traction
wound
contract
nascimentoneto
et
al
effort
halt
transmiss
inhibit
develop
malari
parasit
lectin
celiii
isol
sea
cucumb
cucumaria
echinata
express
genet
modifi
mosquito
lectin
elicit
cytotox
hemolyt
activ
transgen
mosquito
express
celiii
gene
modif
manag
impair
format
ookinet
ookinet
fail
migrat
mosquito
midgut
reproduc
form
daughter
cell
invad
salivari
gland
consequ
infect
human
posit
result
report
observ
ookinet
inhibit
celiii
erythrocyt
lysi
midgut
mosquito
ingest
infecti
blood
suggest
novel
approach
incorpor
genet
engin
control
diseas
yoshida
et
al
use
drug
deliveri
system
transport
pharmaceut
product
target
tissu
much
better
tradit
nontarget
therapeut
smart
drug
deliveri
effici
deliv
medic
diseas
tissu
local
drug
exposur
diseas
tissu
reduc
side
effect
medic
healthi
tissu
thu
increas
treatment
effici
limit
prevent
side
effect
treatment
import
side
effect
typic
lead
reduct
dosag
delay
treatment
therapi
termin
minko
rek
et
al
interact
use
trigger
vesicular
transport
across
epitheli
cell
mani
protein
lipid
cell
membran
glycosyl
glycan
bind
site
lectin
differ
cell
type
express
differ
glycan
array
particular
diseas
cell
often
express
differ
glycan
compar
normal
counterpart
therefor
lectin
could
use
carrier
molecul
target
drug
specif
differ
cell
tissu
kind
receptormedi
bioadhes
may
also
use
convey
signal
cell
order
trigger
vesicular
transport
process
across
polar
epitheli
cell
coupl
macromolecular
drug
particular
drug
carrier
select
suitabl
lectin
may
perhap
allow
cellular
uptak
subsequ
intracellular
rout
deliveri
system
control
haltner
et
al
lectin
may
also
use
target
therapeut
agent
differ
cell
due
properti
increas
microparticl
adher
target
cell
enhanc
penetr
drug
one
applic
use
novel
lipid
microcapsul
drug
deliveri
system
transport
deliv
anticanc
drug
treatment
cancer
eucheuma
serra
agglutinin
esa
deriv
marin
red
alga
eucheuma
serra
lectin
specif
bind
mannoserich
carbohydr
chain
specif
bound
human
colon
adenocarcinoma
cervic
squamou
cell
carcinoma
bind
normal
human
lymphocyt
fibroblast
also
induc
apoptot
cell
death
carcinoma
sarcoma
cell
specif
bind
lectin
cancer
cell
line
base
uniqu
interact
esa
high
mannos
type
sugar
chain
tumor
cell
surfac
sugahara
et
al
esa
incorpor
span
vesicl
use
drug
deliveri
system
esa
bound
vesicl
surfac
act
target
ligand
esa
bound
osteosarcoma
cell
induc
apoptosi
h
result
show
esaincorpor
span
vesicl
potenti
use
osteosarcoma
treatment
via
drug
deliveri
system
addit
encapsul
anticanc
drug
esaincorpor
span
vesicl
expect
provid
extra
antitumor
action
sarcoma
compar
blank
vesicl
hayashi
et
al
problem
associ
drug
deliveri
system
still
tackl
notabl
toxic
immunogen
hope
problem
might
overcom
futur
applic
biotechnolog
techniqu
produc
quantiti
smaller
fragment
lectin
retain
high
target
specif
fascin
molecul
possess
easier
manipul
bie
et
al
lectin
show
high
affin
specif
carbohydr
structur
therefor
use
specif
probe
intracytoplasm
compart
cell
surfac
glycoconjug
histopatholog
histolog
applic
carbohydr
elicit
antibodi
product
due
less
complex
structur
use
lectin
instead
tradit
antibodi
histochem
studi
carbohydr
membran
glycoconjug
becom
common
transform
cell
present
wide
qualit
quantit
variat
glycosyl
pattern
membran
format
carbohydr
cluster
occupi
restrict
area
cell
surfac
allow
interact
lectin
contrast
distribut
homogen
normal
cell
lectin
may
import
tool
obtain
inform
regard
develop
differenti
stage
malign
level
capac
metastasi
tumor
cell
wu
et
al
lectin
design
isol
aqueou
extract
axinella
corrugata
marin
spong
display
strong
agglutin
activ
rabbit
erythrocyt
hemagglutin
inhibit
nacetyl
deriv
like
nacetyldglucosamin
n
nacetyldgalactosamin
nacetyldmannosamin
abl
bind
nacetyldgalactosamin
nacetyldglucosamin
glycan
present
surfac
sever
tumor
cell
includ
bladder
colon
breast
ovari
lung
cancer
cell
line
thu
biotinyl
could
stain
lectin
use
marker
diagnost
also
tissu
map
tool
suspici
neoplasm
biotinyl
acli
could
stain
tumor
cell
might
use
identifi
transform
cell
studi
glycan
structur
synthes
cell
dresch
et
al
one
characterist
malign
cell
relat
abnorm
cell
surfac
protein
glycosyl
shown
abnorm
glycosyl
common
develop
distant
metastas
tumor
progress
corfield
et
al
express
glycoprotein
associ
malign
transform
exampl
compar
normal
colon
cell
express
mucin
colorect
neoplasia
overexpress
baldu
et
al
pinto
et
al
purifi
two
lectin
known
bsl
btl
two
red
marin
alga
genu
bryothamnion
seaforthii
bryothamnion
triquetrum
respect
carbohydratebind
lectin
could
use
discrimin
human
colon
carcinoma
cell
variant
regard
glycoprotein
type
cell
membran
two
lectin
could
bind
mucin
found
cell
surfac
human
colon
adenocarcinoma
cell
line
interact
occur
dosedepend
manner
fluoresc
spectra
could
discrimin
clearli
flow
cytometri
result
besid
two
lectin
bound
glycoprotein
cell
surfac
experienc
extens
intern
observ
confoc
microscop
show
lectin
could
use
target
tool
nowaday
mani
investig
studi
natur
product
isol
marin
speci
divers
pharmacolog
role
hope
develop
new
antimicrobi
antivir
especi
antihiv
agent
antitumor
agent
smith
et
al
vo
kim
lectin
recogn
bind
specif
carbohydr
structur
glycoprotein
glycolipid
proteoglycan
one
investig
target
interact
mediat
via
glycoconjug
induc
cell
regul
patholog
physiolog
action
cellcel
commun
interact
investig
phenomena
applic
becom
popular
larg
number
marin
lectin
isol
number
grow
need
investig
elucid
detail
structureinteractionact
relationship
marin
lectin
order
develop
new
therapeut
agent
one
reason
urgenc
develop
new
therapeut
drug
problem
drug
resist
pathogen
develop
drug
resist
specif
antimicrobi
antivir
may
develop
drug
resist
natur
deriv
similar
action
yasuharabel
lu
henc
differ
antimicrobi
antivir
deriv
produc
speci
may
breakthrough
discoveri
new
drug
furthermor
countless
undefin
uniqu
compound
marin
world
form
attract
reserv
novel
medic
drugresist
pathogen
respect
question
regard
potenti
valu
aforement
marin
lectin
medicin
applic
answer
yet
certain
lectin
resourc
marin
speci
rather
new
date
rel
receiv
commerci
consider
stage
hard
know
lectin
might
persist
meet
success
drug
market
mani
may
pass
muster
problem
toxic
antigen
product
cost
other
might
show
promis
initi
low
stabil
human
bodi
compound
deriv
marin
speci
use
antihiv
agent
shown
play
import
role
diseas
recent
encourag
know
use
marin
lectin
possibl
drug
candid
reduc
control
hiv
infectionrel
chronic
symptom
vo
kim
furthermor
result
impli
antihiv
agent
potenti
use
activ
ingredi
new
drug
discoveri
till
nearli
investig
marin
lectin
deriv
antihiv
agent
test
vitro
anim
model
henc
final
step
novel
drug
develop
must
studi
activ
clinic
trial
